top of page
The root cause,
not just the symptoms
The Problem
Most organizations address whatever problem is most visible. The BMC started somewhere else entirely. We mapped 183 distinct pain points across sponsors, sites, labs, and patients, layered in survey data, and applied a Six Sigma methodology to find the root cause beneath all of them.
That root cause is what we are solving for.
The Problem
Because biospecimen management lacks clear regulatory guidance and enforcement, it gets planned last, communicated poorly, and executed manually across disconnected systems.
The Impact
This results in millions in waste, study delays, data quality issues, and increased patient burden.
Why We Exist
Nobody is fixing it because the work cuts across organizational silos that do not share objectives, timelines, or data models - until now.
Our 2026 Focus
Three documents. Built separately. Never aligned.
The protocol, the biospecimen plan, and the lab manual govern everything about how a sample is collected, handled, and analyzed in a clinical trial. They are written by different people, on different timelines, with no shared standard. When they conflict, sites improvise, quality suffers, and patients bear the cost.
Aligning these three documents is where the fix begins.
What the BMC is building: a standardized, cross-ecosystem framework that keeps these documents in sync from the start.
bottom of page